Patent · US Active

Pharmaceutical formulation containing an opioid agonist, opioid antagonist and irritant agent

US8652515B2 · kind B2 · utility

72Cited by
29References
21Claims
0Family size

Assignee

Inventor

Key dates

Filing dateSep 12, 2011
Grant dateFeb 18, 2014
Priority date—
Expiry dateFeb 2, 2032

Classification

  • Technology area (CPC A)Human Necessities
  • CPC primaryA61K9/2027
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

Disclosed in certain embodiments is an oral dosage form comprising:

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.